EBITDA Margin % is calculated as EBITDA divided by its Revenue. McKesson's EBITDA for the
three
months ended in Dec. 2023 was $835 Mil. McKesson's Revenue for the
three
months ended in Dec. 2023 was $80,898 Mil. Therefore, McKesson's EBITDA margin for the quarter that ended in Dec. 2023 was 1.03%.
McKesson EBITDA Margin % Historical Data
The historical data trend for McKesson's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of McKesson's EBITDA Margin %
For the Medical Distribution subindustry, McKesson's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
McKesson's EBITDA Margin % Distribution in the Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, McKesson's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where McKesson's EBITDA Margin % falls into.
McKesson EBITDA Margin % Calculation
EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.
McKesson's EBITDA Margin % for the fiscal year that ended in Mar. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
McKesson (NYSE:MCK) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
McKesson EBITDA Margin % Related Terms
Thank you for viewing the detailed overview of McKesson's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
McKesson Corp is one of three leading pharmaceutical wholesalers in the U.S. engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the U.S. pharmaceutical wholesale industry. Outside the U.S. market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MCK has been successfully added to your 